JP2012502014A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502014A5 JP2012502014A5 JP2011525613A JP2011525613A JP2012502014A5 JP 2012502014 A5 JP2012502014 A5 JP 2012502014A5 JP 2011525613 A JP2011525613 A JP 2011525613A JP 2011525613 A JP2011525613 A JP 2011525613A JP 2012502014 A5 JP2012502014 A5 JP 2012502014A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- compound according
- optionally substituted
- following formula
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 26
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 102000011727 Caspases Human genes 0.000 claims 3
- 108010076667 Caspases Proteins 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 210000004962 mammalian cell Anatomy 0.000 claims 3
- 150000003852 triazoles Chemical class 0.000 claims 3
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims 2
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 claims 2
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 claims 2
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 125000005331 diazinyl group Chemical class N1=NC(=CC=C1)* 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000006575 electron-withdrawing group Chemical group 0.000 claims 2
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 2
- 239000012216 imaging agent Substances 0.000 claims 2
- 238000003384 imaging method Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 150000003527 tetrahydropyrans Chemical class 0.000 claims 2
- 125000001425 triazolyl group Chemical group 0.000 claims 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 230000006907 apoptotic process Effects 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 238000011002 quantification Methods 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 238000012800 visualization Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0816294A GB0816294D0 (en) | 2008-09-05 | 2008-09-05 | Compounds |
| GB0816294.3 | 2008-09-05 | ||
| GB0818076A GB0818076D0 (en) | 2008-10-02 | 2008-10-02 | Compounds |
| GB0818076.2 | 2008-10-02 | ||
| PCT/GB2009/002132 WO2010026388A1 (en) | 2008-09-05 | 2009-09-04 | Isatin derivatives for use as in vivo imaging agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012502014A JP2012502014A (ja) | 2012-01-26 |
| JP2012502014A5 true JP2012502014A5 (enExample) | 2012-10-25 |
| JP5667056B2 JP5667056B2 (ja) | 2015-02-12 |
Family
ID=41181051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011525613A Expired - Fee Related JP5667056B2 (ja) | 2008-09-05 | 2009-09-04 | インビボ画像化剤として使用されるイサチン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8961930B2 (enExample) |
| EP (1) | EP2367816B1 (enExample) |
| JP (1) | JP5667056B2 (enExample) |
| KR (1) | KR20110066927A (enExample) |
| CN (1) | CN102171208A (enExample) |
| AU (1) | AU2009289062B2 (enExample) |
| CA (1) | CA2735970A1 (enExample) |
| MX (1) | MX2011002498A (enExample) |
| RU (1) | RU2535975C2 (enExample) |
| WO (1) | WO2010026388A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2013010012A (es) | 2011-03-01 | 2014-04-14 | Ge Healthcare Ltd | Analogos de octreotato radiomarcado como trazadores de tomografia por emision de positrones. |
| GB201121911D0 (en) | 2011-12-20 | 2012-02-01 | Ge Healthcare Ltd | Radiofluorination method |
| CN103183631B (zh) * | 2011-12-28 | 2016-08-24 | 天津市国际生物医药联合研究院 | 靛红-5-磺酰胺类衍生物及其在制备治疗非典型性肺炎的药物中的应用 |
| BR112018072494B1 (pt) * | 2016-05-10 | 2022-01-11 | Fundação Oswaldo Cruz | Composto derivado de isatina, e, uso do composto |
| CN115171929B (zh) * | 2021-04-01 | 2024-07-16 | 中核核电运行管理有限公司 | 重水堆机组给水支管与燃料通道小间隙问题处理的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1240648A (en) | 1967-08-16 | 1971-07-28 | Wyeth John & Brother Ltd | N-substituted isatins |
| AR016384A1 (es) | 1997-07-30 | 2001-07-04 | Smithkline Beecham Corp | Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta. |
| JP2003510278A (ja) | 1999-09-30 | 2003-03-18 | スミスクライン・ビーチャム・コーポレイション | カスパーゼおよびアポプトシス |
| HRP20020751B1 (hr) * | 2000-02-15 | 2011-01-31 | Sugen | Pirolom supstituirani 2-indolinoni kao inhibitori protein kinaze |
| RU2259999C2 (ru) * | 2003-08-26 | 2005-09-10 | ООО "Исследовательский институт химического разнообразия" | 1-сульфонил-1,3-дигидроиндол-2-оны, фармацевтические композиции (варианты), способ их получения и применения |
| GB0327494D0 (en) | 2003-11-26 | 2003-12-31 | Amersham Plc | Novel imaging agents |
| US7270799B2 (en) | 2004-01-15 | 2007-09-18 | Nst Neurosurvival Technologies Ltd. | Perturbed membrane-binding compounds and methods of using the same |
| US7256198B2 (en) | 2004-02-18 | 2007-08-14 | Wyeth | Pyrimidoindolones and methods for using same |
| GB0428012D0 (en) | 2004-12-22 | 2005-01-26 | Hammersmith Imanet Ltd | Radiolabelling methods |
| WO2006074799A2 (en) | 2005-01-17 | 2006-07-20 | Universitätsklinikum Münster | 5-pyrrolidinylsulfonyl isatin derivatives |
-
2009
- 2009-09-04 EP EP09785058.0A patent/EP2367816B1/en not_active Not-in-force
- 2009-09-04 CN CN2009801389781A patent/CN102171208A/zh active Pending
- 2009-09-04 WO PCT/GB2009/002132 patent/WO2010026388A1/en not_active Ceased
- 2009-09-04 MX MX2011002498A patent/MX2011002498A/es not_active Application Discontinuation
- 2009-09-04 RU RU2011112075/04A patent/RU2535975C2/ru not_active IP Right Cessation
- 2009-09-04 CA CA2735970A patent/CA2735970A1/en not_active Abandoned
- 2009-09-04 JP JP2011525613A patent/JP5667056B2/ja not_active Expired - Fee Related
- 2009-09-04 KR KR1020117007647A patent/KR20110066927A/ko not_active Ceased
- 2009-09-04 US US13/062,064 patent/US8961930B2/en active Active
- 2009-09-04 AU AU2009289062A patent/AU2009289062B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019520328A5 (enExample) | ||
| Grönroos et al. | Comparison of the biodistribution of two hypoxia markers [18F] FETNIM and [18F] FMISO in an experimental mammary carcinoma | |
| CN109200296B (zh) | 用于合成显像剂和其中间体的方法和装置 | |
| Buchmann et al. | [18F] 3'-Deoxy-3'-Fluorothymidine-PET in NHL Patients: Whole-Body Biodistribution and Imaging of Lymphoma Manifestations—a Pilot Study | |
| Dummer et al. | Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma | |
| Pieper et al. | Speckle-tracking 2-dimensional strain echocardiography: a new noninvasive imaging tool to evaluate acute rejection in cardiac transplantation | |
| JP2010535210A5 (enExample) | ||
| JP6936335B2 (ja) | 腺様嚢胞がんの治療のためのベンゼンスルホンアミド誘導体の医薬組成物 | |
| JP2022020696A (ja) | 脂質組成のマイクロバブル及びその製造方法 | |
| Brink et al. | Lymph node staging in extracranial head and neck cancer with FDG PET–appropriate uptake period and size-dependence of the results | |
| JP2007515467A5 (enExample) | ||
| JP2012504581A5 (enExample) | ||
| JP2009538894A5 (enExample) | ||
| JP2013507345A5 (enExample) | ||
| Abele et al. | Lymphoscintigraphy in early-stage non-small cell lung cancer with technetium-99m nanocolloids and hybrid SPECT/CT: a pilot project | |
| Chrastina et al. | Experimental model of transthoracic, vascular-targeted, photodynamically induced myocardial infarction | |
| JP2011251968A5 (enExample) | ||
| JP2013509378A5 (enExample) | ||
| RU2011112075A (ru) | Производные изатина для применения в качестве агентов визуализации in vivo | |
| GW Kosterink | Positron emission tomography in the diagnosis and treatment management of tuberculosis | |
| JP2012520855A5 (enExample) | ||
| KR20160086962A (ko) | 삼중 음성 유방 암 치료를 위해 카보플라틴과 병용된 벨리파리브 | |
| Slevin et al. | The diagnostic value of positron emission tomography (PET) with radiolabelled fluorodeoxyglucose (18F-FDG) in head and neck cancer | |
| EP4188453A1 (en) | Methods and materials for using [18f]-f-arag in cardiac imaging | |
| WO2020017557A1 (ja) | 新規化合物、および、その利用 |